FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD
Links shared publicly online about this topic.
- 1,287total visits
FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD
View full resource at news-medical.net
Tags: Neuropathic Pain Medication, Disease and Condition, Drug, Pharma, FDA, Sifrol, Mirapex, Boehringer Ingelheim
Most Recently Shared on March 26, 2010 at 11:38 am By:
Parkinson's Disease: FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD: Boehringer Ingelheim... http://bit.ly/9ct9qR
Mirapex ER approved for advanced Parkinson's Disease - ONA
oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer Ingelheim) for the signs and symptoms of advanced idiopathic Parkinson--™s disease (PD).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 23, 2010 at 3:59 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Mirapex ER approved for advanced Parkinson's Disease http://goo.gl/fb/FEnz
Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., ” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 10:12 am By:
Parkinson's Disease: Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of ear... http://bit.ly/c33J2g
Mirapex ER approved for early Parkinson's disease - ONA
oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer-Ingelheim Pharmaceuticals) as a treatment for the signs and symptoms of early idiopathic Parkinson--™s disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 22, 2010 at 5:44 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Mirapex ER approved for early Parkinson's disease http://goo.gl/fb/pcsE
Advertisement
